Division for Cancer Pharmacology – Young Investigators Symposium
Monday April 23, 2018
3:30 pm
-
6:00 pm
Eastern Time (ET)
Room 15B
DCP
Chair :
Christine Canman
University of Michigan Medical School
Jack Yalowich
Ohio State University
This session showcases abstract-based oral presentations by graduate student and postdoctoral ASPET members focused on cancer pharmacology.
Speakers
Shu Wiley
- University of California, San Diego
GPR68, A Proton Sensing GPCR, Mediates Interaction of Pancreatic Cancer Associated Fibroblasts and Cancer Cells
Tawna Whited
- Case Western Reserve University
Deciphering the Role of SLX4IP in Telomere Maintenance Mechanisms
Megan Zavorka Thomas
- The Ohio State University
S100A8 and S100A9 Proteins in Tyrosine Kinase Inhibitor Resistance in FLT3-ITD-Positive Acute Myeloid Leukemia
Jessica Waninger
- University of Michigan Ann Arbor
Structural Characterization of KRAS with a Novel Interactor, Argonaute 2
Joseph Jilek
- University of California, Davis
Bioengineered let-7c is Effective at Reducing Orthotopic Hepatocellular Carcinoma Tumor Burden and is Well Tolerated in Mouse Models
Rebecca Crawford
- St Jude Children's Research Hospital
Genetic Ablation of the ABC Transporter Abcc4 Impairs Lymphoid Leukemogenesis
Wen An Pan
- University of California, San Diego
Tumor Suppressor Alpha-arrestin ARRDC3 Controls GPCR Signaling and Breast Cancer Chemoresistance